Mary L. Schuckmann
FDA investigator
Appears on 2 documents from 2024 to 2025, mostly at sites in Illinois. Most often cites design and construction features (21 CFR 211.42).
- 2
- Documents on file
- 6.0
- Observations per 483
- 2024
- First seen
- 2025
- Most recent
What they cite most
From 12 observations- 21 CFR 211.42Design and construction features3
- 21 CFR 211.110Sampling and testing of in-process materials and drug products2
- 21 CFR 211.160General requirements2
- 21 CFR 211.192Production record review2
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.113Control of microbiological contamination1
Activity by year
2024: 1, 2025: 1
Where
Illinois 1 · Missouri 1
Often inspects with
Is Mary L. Schuckmann coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2025-04-28 | 483 Sigma-Aldrich Manufacturing LLCApr 28, 2025 · Saint Louis, Missouri | Saint Louis, Missouri | 4 | |
| 2024-05-01 | 483 Sterling Pharmaceutical Services, LLCMay 1, 2024 · East Carondelet, Illinois | East Carondelet, Illinois | 8 |
About this profile
What does Mary L. Schuckmann inspect?
Mary L. Schuckmann appears on 2 documents on file covering 2 sites, mostly in Illinois.
What do they cite most often?
21 CFR 211.42 (design and construction features), followed by 21 CFR 211.110 and 21 CFR 211.160.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Mary L. Schuckmann is dated Apr 28, 2025.